Metabolic health is an umbrella concept, not a single diagnosis with one universally accepted test. In practice, assessment draws on blood glucose, blood lipids, blood pressure, waist circumference and related risk factors — including insulin response and abdominal fat distribution.
Clinically, this is captured through the concept of metabolic syndrome. Under the widely used ATP III criteria, the diagnosis applies when at least 3 of 5 conditions are met: enlarged waist circumference, elevated triglycerides, low HDL cholesterol, elevated blood pressure (or treatment for hypertension), and elevated fasting glucose (or treatment for diabetes). The historical 2005 IDF definition required an enlarged waist plus two other components. The joint 2009 harmonized statement, also involving IDF, makes no component obligatory: three of five qualify, using an appropriate regional waist cutoff.
It helps to think of this as a spectrum, not an on/off switch. Most people are neither clearly fine nor clearly at risk — they sit somewhere in between, which is exactly where tracking a trend early matters. And that is also where this article draws its line: some pieces of the mosaic can be seen without a needle, others genuinely cannot.